Philip Speakman Email & Phone Number

Edinburgh, United Kingdom

I have been associated with Quantics since 2005, firstly as a client when at Avecia and PharmAthene and I am now delighted to oversee the next phase of our business growth alongside an exceptional team with a truly international and loyal client base. Joining as a former client, I truly understand the importance of helping you define the question you need to ask of your data, how we can help you to interpret and analyse it and then explain the results in a way you can understand. I am… Show more I have been associated with Quantics since 2005, firstly as a client when at Avecia and PharmAthene and I am now delighted to oversee the next phase of our business growth alongside an exceptional team with a truly international and loyal client base. Joining as a former client, I truly understand the importance of helping you define the question you need to ask of your data, how we can help you to interpret and analyse it and then explain the results in a way you can understand. I am delighted to now be leading the team to continue this approach with all our clients today. Show less

Leeds And Edinburgh Uk

Manchester, Uk

25 Years Management and Leadership Experience in the Lifescience and Biodefence IndustriesStrategy Development and ExecutionNon-Executive DirectorDue Diligence, Licensing, Mergers and AcquisitionsIdentifying and Securing Unleveraged FinanceCommercial and Marketing ManagementGovernment Proposals, Contracting and Complaince

Zürich Area, Switzerland

Led the vendor evaluation, selection and contracting with subcontractors for the development and manufacturing of recombinant lectins.

Leeds Uk And Annapois Md,

Head of European OperationsLicensing, Mergers and AcquisitionsGovernment Relations and Subcontractor Management

Teesside Uk And Milford Ma

Led Finance, Contracting and Commercial TeamsCorporate and Strategic DevelopmentLicensing and Commercial OperationsGovernment Contracting, Subcontracting and Proposal Development

Led all aspects of the Plague Vaccine Development ProgrammeSecured additional non-leveraged fundingFrom pilot manufacture to completion of Day 0 dosing < 12 months

Manchester Uk And Milford Ma.

Developed a stable and secure supply chain for complex oligonucleotideMany materials had never been available at the required scaleAcquired technology and capability to secure critical raw materialsLed a program to purge the supply chain of all animal derived products

Manchester Uk And Toronto

Identified and acquired 5 companies/businesses in 3 yearsLed multi-disciplinary Due Diligence teams in many international targetsLed many board level presentations to gain support for strategic investments